Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.7951
-0.1195 (-13.07%)
At close: Nov 16, 2026, 4:00 PM EST
0.8400
+0.0449 (5.65%)
Pre-market: Nov 17, 2026, 8:35 AM EST

Lineage Cell Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
26.540.7945.7935.4411.3655.74
Short-Term Investments
18.6814.992.020.0546.522.62
Cash & Short-Term Investments
45.1855.7847.8135.4957.8858.36
Cash Growth
11.58%16.68%34.69%-38.67%-0.83%40.41%
Accounts Receivable
1.331.560.640.750.350.84
Receivables
1.331.560.640.750.350.84
Prepaid Expenses
1.271.792.552.21.832.35
Other Current Assets
-0.02----
Total Current Assets
47.7759.165138.4460111.55
Property, Plant & Equipment
4.074.74.44.775.674.87
Goodwill
10.6710.6710.6710.6710.6710.67
Other Intangible Assets
31.731.746.5446.5646.6946.82
Long-Term Deferred Tax Assets
5.315.8----
Other Long-Term Assets
0.580.560.610.580.630.63
Total Assets
100.11112.58113.22101.02123.66174.55

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.642.341.172.052.393.54
Accrued Expenses
3.974.844.264.226.2224.25
Current Portion of Leases
0.990.851.150.880.950.83
Current Unearned Revenue
1.423.337.3910.819.4218.12
Other Current Liabilities
-----0.38
Total Current Liabilities
8.0211.3713.9817.9618.9847.12
Long-Term Leases
1.041.571.362.072.941.97
Long-Term Unearned Revenue
12.3412.3814.4318.6927.7332.45
Long-Term Deferred Tax Liabilities
0.010.020.270.272.082.08
Other Long-Term Liabilities
12.7543.916.16-00.03
Total Liabilities
34.1769.2436.213951.7383.65

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
537.42515.47484.72451.34440.28434.53
Retained Earnings
-466.1-467-403.47-384.86-363.37-337.1
Comprehensive Income & Other
-4.26-3.92-2.88-3.07-3.57-5.21
Total Common Equity
67.0644.5578.3863.4273.3492.22
Minority Interest
-1.12-1.2-1.37-1.4-1.4-1.32
Shareholders' Equity
65.9443.3577.0162.0271.9490.9
Total Liabilities & Equity
100.11112.58113.22101.02123.66174.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2.032.422.512.953.92.8
Net Cash (Debt)
43.1553.3645.2932.5453.9855.56
Net Cash Growth
13.95%17.82%39.19%-39.72%-2.84%47.22%
Net Cash Per Share
0.170.230.230.190.320.34
Filing Date Shares Outstanding
252.95249.09228.36188.53170.15169.71
Total Common Shares Outstanding
252.91243.12220.42174.99170.09169.48
Working Capital
39.7647.7937.0220.4841.0264.43
Book Value Per Share
0.270.180.360.360.430.54
Tangible Book Value
24.692.1821.176.1915.9834.73
Tangible Book Value Per Share
0.100.010.100.040.090.20
Machinery
5.375.284.133.613.263.47
Leasehold Improvements
2.922.752.32.312.152.54
SEC Filings: 10-K · 10-Q